The objective of this study is to test the scale structure, reliability, validity and responsiveness to change of the QLQ-CML24 in conjuction with the QLQ-C30 for patients diagnosed with CML, and to investigate longitudinal relationship between satisfaction with information provision and QoL outcomes.
Study Type
OBSERVATIONAL
Enrollment
337
The primary objective of the study is to test the scale structure, reliability, validity and responsiveness to change of the QLQ-CML24 in conjunction with the QLQ-C30 for patients diagnosed with CML.
Time frame: 18 months from enrollment
The secondary objective is to investigate longitudinal relationship between satisfaction with information provision (outcome measure: EORTC INFO-25) and QoL outcomes (outcome measures: EORTC QLQ-C30 and QLQ-CML24).
Time frame: 18 months from enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Winship Cancer Institute of Emory University
Emory, Georgia, United States
Innsbruck Medical University
Innsbruck, Austria
Complexo Hospital de Clinicas da Universidade Federal do Parana
Paranã, Brazil
Guangdong Medical University
Guangdong, China
Universität Heidelberg
Heidelberg, Germany
Baghdad Teaching Hospital
Baghdad, Iraq
Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi
Ancona, Italy
Azienda Ospedaliero-Universitaria Policlinico Consorziale
Bari, Italy
Department of Oncology and Hematology, O.U. of Hematology, S. Orsola-Malpighi University Hospital, Bologna
Bologna, Italy
Sezione di Ematologia e Trapianti Spedali Civili
Brescia, Italy
...and 22 more locations